Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Pleuropulmonary Blastoma Registry, |
RCV000240963 | SCV000195590 | pathogenic | DICER1-related tumor predisposition | 2014-11-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000493145 | SCV000581613 | pathogenic | Hereditary cancer-predisposing syndrome | 2023-06-01 | criteria provided, single submitter | clinical testing | The c.2392dupA pathogenic mutation, located in coding exon 14 of the DICER1 gene, results from a duplication of A at nucleotide position 2392, causing a translational frameshift with a predicted alternate stop codon (p.T798Nfs*33). This alteration has been observed in individuals with a personal and/or family history that is consistent with DICER1-related disease (Hill DA et al. Science, 2009 Aug;325:965; Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Foulkes Cancer Genetics LDI, |
RCV000240963 | SCV001371983 | pathogenic | DICER1-related tumor predisposition | 2019-07-01 | criteria provided, single submitter | curation | ACMG criteria met: PVS1, PM2, PP4 |
OMIM | RCV002282086 | SCV000024904 | pathogenic | Pleuropulmonary blastoma | 2009-08-21 | no assertion criteria provided | literature only |